MI MANGOCEUTICALS, INC. Stock: price and insider trades · United States · SEC (Form 4)Track the MANGOCEUTICALS, INC. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €8.4m. The latest transaction was filed on 20 March 2026 (Don). Among the most active insiders: Cohen Jacob D.. All data is accessible without an account.
€154,930
5 ops.
Sell Volume
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 March 2026
All Executives26 Thresholds0 Prospectus0 Other0
Declarations 26 total
● Chief Executive Officer · Executives · 5 Jun 2025
200,000 shares 0Common Stock SEC:0001493152-26-011921:0
▼ CFO · Executives · 15 Dec 2025
3,333 shares @ US$1.1653 18.3% of flow Common Stock SEC:0001493152-25-028193:0
▼ CFO · Executives · 9 Dec 2025
5,000 shares @ US$1.195 34.6% of flow Common Stock SEC:0001493152-25-027238:0
▼ CFO · Executives · 5 Dec 2025
10,000 shares @ US$1.128 100.0% of flow Common Stock SEC:0001493152-25-026923:0
▼ Director · Executives · 19 Nov 2025
125,000 shares @ US$1.223 96.5% of flow Common Stock SEC:0001493152-25-025163:0
◆ Chief Executive Officer · Executives · 10 Apr 2025
200,000 shares 0Common Stock SEC:0001493152-25-016352:0
◆ Director · Executives · 9 Sept 2025
100,000 shares 0Common Stock SEC:0001641172-25-027217:0
◆ Chief Financial Officer · Executives · 9 Sept 2025
100,000 shares 0Common Stock SEC:0001641172-25-027218:0
◆ Director · Executives · 9 Sept 2025
100,000 shares 0Common Stock SEC:0001641172-25-027219:0
◆ Director · Executives · 9 Sept 2025
100,000 shares 0Common Stock SEC:0001641172-25-027216:0
◆ President · Executives · 10 Apr 2025
60,000 shares 0Common Stock SEC:0001641172-25-003876:0
◆ Chief Executive Officer · Executives · 10 Apr 2025
200,000 shares 0Common Stock SEC:0001641172-25-003873:0
◆ Director · Executives · 10 Apr 2025
25,000 shares 0Common Stock SEC:0001641172-25-003877:0
◆ Director · Executives · 10 Apr 2025
25,000 shares 0Common Stock SEC:0001641172-25-003875:0
◆ Director · Executives · 10 Apr 2025
25,000 shares 0Common Stock SEC:0001641172-25-003874:0
◆ Chief Financial Officer · Executives · 11 Nov 2024
25,000 shares 0Common Stock SEC:0001493152-24-044832:0
● Chief Executive Officer · Executives · 26 Aug 2024
800,000 shares 0Common Stock SEC:0001493152-24-034060:0
▼ Director · Executives · 25 Jun 2024
16,574 shares @ US$0.31 100.0% of flow Common Stock SEC:0001493152-24-025489:0
◆ Chief Executive Officer · Executives · 3 Jun 2024
800,000 shares 0Common Stock SEC:0001493152-24-022803:0
◆ Director · Executives · 3 Jun 2024
100,000 shares 0Common Stock SEC:0001493152-24-022805:0
◆ Director · Executives · 3 Jun 2024
100,000 shares 0Common Stock SEC:0001493152-24-022807:0
◆ Director · Executives · 3 Jun 2024
100,000 shares 0Common Stock SEC:0001493152-24-022804:0
◆ Chief Operating Officer · Executives · 3 Jun 2024
100,000 shares 0Common Stock SEC:0001493152-24-022806:0
◆ Chief Financial Officer · Executives · 3 Oct 2023
50,000 shares 0Common Stock SEC:0001493152-23-035677:0
◆ Chief Operating Officer · Executives · 1 May 2023
75,000 shares 0Common Stock SEC:0001493152-23-015393:0
25 of 26 declarations
Load more (1 remaining) 关于 MANGOCEUTICALS, INC. MANGOCEUTICALS, INC. 是一家在 XNAS 市场上市的公司，专注于创新药物产品的开发。该公司致力于通过先进的治疗解决方案提升健康和福祉。